Medications for the respiratory system
Antibiotics | Free Full-Text | Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice | HTML
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients | NEJM
Table 1 from Four phases of intravenous fluid therapy: a conceptual model. | Semantic Scholar
Provider perceptions of severe pediatric traumatic brain injury care priorities across hospitals in South America before and during the COVID-19 pandemic | PLOS ONE
Oral administration - Wikipedia
Per os therapy – Apimell
Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness | BMC Cancer | Full
Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non–High-Dose Methotrexate–Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center | JCO Global Oncology
Colchicine for Early COVID-19? Trial May Support Oral Therapy at Home | MedPage Today
Switch over from intravenous to oral therapy: A concise overview | Semantic Scholar
Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. - Abstract - Europe PMC
JCM | Free Full-Text | Clostridioides difficile Infection in Patients after Organ Transplantation—A Narrative Overview | HTML
AUTOIMMUNE BULLOUS DISEASE MEDICATIONS
Patient's counseling with an increased INR level / OSCE guide | ClinCaseQuest
Pharmacokinetics of different phage application strategies.... | Download Scientific Diagram
Absorption of drugs from non per os extravascular administration
Septicemia, necrotizing fasciitis, and peritonitis due to Vibrio vulnificus treated with early use of polymyxin B hemoperfusion in a patient undergoing CAPD: a case report | SpringerLink
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer -
OS rate curves. (A) OS and (B) OS after therapy with BDR per ISSWM stage. | Download Scientific Diagram
Vaccine therapy of bacillary dysentery per os. K. T. Glukhov, E. A. Volkova, G. L. Erusalimchik and L. G. Panina (Prof. Med., 1926, No. 7-8) - Board - Kazan medical journal
